A CASE OF DIFFUSE LARGE B-CELL LYMPHOMA TRANSFORMED FROM FOLLICULAR LYMPHOMA WITH SUCCESSFUL GRAFT-VERSUS-LYMPHOMA EFFECT ON EARLY RELAPSE AFTER CORD BLOOD TRANSPLANTATION-Reference-Cited by-同舟云学术

A CASE OF DIFFUSE LARGE B-CELL LYMPHOMA TRANSFORMED FROM FOLLICULAR LYMPHOMA WITH SUCCESSFUL GRAFT-VERSUS-LYMPHOMA EFFECT ON EARLY RELAPSE AFTER CORD BLOOD TRANSPLANTATION

Published:2021-12-24 Issue:6 Volume:67 Page:601-606
ISSN:1881-3011
Container-title:Japanese Journal of Transfusion and Cell Therapy
language:en
Short-container-title:JJTC

Author:

Maegaki Masaya¹,Adachi Koji¹,Kawamura Koji²,Tazawa Chiaki³,Nishio Takaya³,Hamada Nozomi¹,Hara Kentaro²,Suzuki Sayaka²,Hosoda Yuzuru²,Tajima Fumihito¹,Fukuda Tetsuya²,Suzumiya Junji⁴

Affiliation:

1. Stem Cell Transplantation Center, NHO, Yonago Medical Center

2. Department of Hematology, Tottori University Hospital

3. Division of Clinical laboratory, NHO, Yonago Medical Center

4. Department of Hematology, Sunkohkai Koga Hospital

Publisher

Japan Society of Transfusion Medicine and Cell Therapy

Subject

Computer Networks and Communications,Hardware and Architecture,Software

Link

https://www.jstage.jst.go.jp/article/jjtc/67/6/67_601/_pdf

Reference16 articles.

1. 1) Peggs KS, Mackinnon S, Linch DC: The role of allogeneic transplantation in non-Hodgkin's lymphoma. Br J Haematol, 128: 153-168, 2005.

2. 2) Dreger P, Timothy S, Fenske TS, et al: Cellular immunotherapy for refractory diffuse large B cell lymphoma in the chimeric antigen receptor-engineered T cell era: still a role for allogeneic transplantation? Biol Blood Marrow Transplant, 26: e77-e85, 2020.

3. 3) Hirayama AV, Gauthier J, Hay KA, et al: High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy. Blood, 134: 636-640, 2019.

4. 4) Smith SM, Godfrey J, Ahn KW, et al: Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure. Cancer, 124: 2541-2551, 2018.

5. 5) Tomblyn MR, Ewell M, Bredeson C, et al: Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response. Biol Blood Marrow Transplant, 17: 1051-1057, 2011.